COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,686 Articles (22,913 medRxiv, 8,773 bioRxiv)

Most recent first Previous |  Page 1799: Articles 17981-17990  | Next

COVID-19 Related Chemosensory Changes in Individuals with Self-Reported Obesity
Buthani, S., Coppin, G., Veldhuizen, M. G., Parma, V., Joseph, P. V.
10.1101/2021.02.28.21252536 — Posted: 2021-03-02
Distinct systemic and mucosal immune responses to SARS-CoV-2
Smith, N., Goncalves, P., Charbit, B., Grzelak, L., Beretta, M., Planchais, C., Bruel, T., Rouilly, V., Bondet, V., hadjadj, j., Yatim, N., Pere, H., Merkling, S., Kerneis, S., Rieux-Leucat, F., Terrier, B., Schwartz, O., Mouquet, H., Duffy, D., Di Santo, J.
10.1101/2021.03.01.21251633 — Posted: 2021-03-02
Novel clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health
Su, C., Zhang, Y., Flory, J. H., Weiner, M. G., Kaushal, R., Schenck, E. J., Wang, F.
10.1101/2021.02.28.21252645 — Posted: 2021-03-02
Effect Monitoring and Insights from Vaccination program of Healthcare Workforce from a tertiary level hospital in India against SARS-CoV-2.
Ujjainiya, R., Tyagi, A., Sardana, V., Naushin, S., Bhatheja, N., Kumar, K., Barman, J., Prakash, S., Kutum, R., Loomba, M., Khanna, Y., Walecha, C., Ahmed, R., Yadav, A., Bajaj, A., Malik, G., Qureshi, S., Waghdhare, S., Siddiqui, S., Trehan, K. K., Mani, M., Dang, R., Das, P., Dougall, P., Mahajan, M., Buddhiraja, S., Agrawal, A., Dash, D., Jha, S., Sengupta, S.
10.1101/2021.02.28.21252621 — Posted: 2021-03-02
The Risks and Benefits of Providing HIV Services during the COVID-19 Pandemic
Stover, J., Kelley, S. L., Mudimu, E., Green, D., Smith, T., Taramusi, I., Bansi-Matharu, L., Martin-Hughes, R., Phillips, A. N., Bershteyn, A.
10.1101/2021.03.01.21252663 — Posted: 2021-03-02
The impact of COVID-19 on primary health care and antibiotic prescribing in rural China: qualitative study
Zhang, T., Shen, X., Liu, R., Zhao, L., Wang, D., Lambert, H., Cabral, C.
10.1101/2021.03.01.21252602 — Posted: 2021-03-02
Optimal mobility restriction minimizing COVID-19 and excess suicide deaths in Japan
Kurita, J., Sugawara, T., Sugishita, Y., Ohkusa, Y.
10.1101/2021.02.28.21252644 — Posted: 2021-03-02
Vaccine hesitancy and reasons for refusing the COVID-19 vaccination among the U.S. public: A cross-sectional survey
Raja, A. S., Niforatos, J. D., Anaya, N., Graterol, J., Rodriquez, R. M.
10.1101/2021.02.28.21252610 — Posted: 2021-03-02
SARS-CoV-2 infection in households with and without young children: Nationwide cohort study
Husby, A., Corn, G., Krause, T. G.
10.1101/2021.02.28.21250921 — Posted: 2021-03-02 Discussion: Onsite
Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal
Meireles, P., Amaro, J., Costa, J. P., Mendes Lopes, M., Varandas, T., Norton, P., Guimaraes, J. T., Severo, M., Barros, H.
10.1101/2021.02.28.21252628 — Posted: 2021-03-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).